The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Open accessAbstract
The coumarin (benzopyran-2-one, or chromen-2-one) ring system, present in natural products (such as the anticoagulant warfarin) that display interesting pharmacological properties, has intrigued chemists and medicinal chemists for decades to explore the natural coumarins or synthetic analogs for their applicability as drugs. Many molecules based on the coumarin ring system have been synthesized utilizing innovative synthetic techniques. The diversity oriented synthetic routes have led to interesting derivatives including the furanocoumarins, pyranocoumarins, and coumarin sulfamates (COUMATES), which have been found to be useful in photochemotherapy, antitumor and anti-HIV therapy, and as stimulants for central nervous system, antibacterials, anti-inflammatory, anti-coagulants, and dyes. Of particular interest in breast cancer chemotherapy, some coumarins and their active metabolite 7-hydroxycoumarin analogs have shown sulfatase and aromatase inhibitory activities. Coumarin based selective estrogen receptor modulators (SERMs) and coumarin-estrogen conjugates have also been described as potential antibreast cancer agents. Since breast cancer is the second leading cause of death in American women behind lung cancer, there is a strong impetus to identify potential new drug treatments for breast cancer. Therefore, the objective of this review is to focus on important coumarin analogs with antibreast cancer activities, highlight their mechanisms of action and structure-activity relationships on selected receptors in breast tissues, and the different methods that have been applied in the construction of these pharmacologically important coumarin analogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Heterocyclic Chemistry II
KATRITZKY, A. R., Rees, C. W., & Scriven, E. F. V. (1997) · Medical Entomology and Zoology · Cited by 8,499
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase
Kitz, R., & Wilson, I. B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50153-8 · Cited by 1,519
Simple Coumarins and Analogues in Medicinal Chemistry: Occurrence, Synthesis and Biological Activity
Borges, F., Roleira, F., Milhazes, N., Santana, L., & Uriarte, E. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053507315 · Cited by 994
Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities
Fylaktakidou, K., Hadjipavlou-Litina, D., Litinas, K., & Nicolaides, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382710 · Cited by 970
Hoult, J. R. S., & Payá, M. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02112-4 · Cited by 951
The natural coumarins : occurrence, chemistry, and biochemistry
Murray, R. D., Méndez, J., & Brown, S. A. (1982) · Andalas University Repository (Andalas University) · Cited by 793
Eiermann, W., Paepke, S., Appfelstaedt, J., Llombart-Cussac, A., Eremin, J., Vinholes, J., Mauriac, L., Ellis, M., Lassus, M., Chaudri-Ross, H. A., et al. (2001) · Annals of Oncology · doi:10.1023/a:1013128213451 · Cited by 713
Multistage carcinogenesis in mouse skin
DiGiovanni, J. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90051-z · Cited by 642
Lacy, A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382693 · Cited by 635
The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds
Egan, D., O'kennedy, R., Moran, E., Cox, D., Prosser, E., & Thornes, R. D. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539008991449 · Cited by 558
Steroid sulfatase: molecular biology, regulation, and inhibition
Reed, M. J., Purohit, A., Woo, L. W. L., Newman, S. P., & Potter, B. V. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0003 · Cited by 524
Sulfonation and molecular action
Strott, C. A. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0040 · Cited by 487
Cancer of the Breast: The Past Decade
Henderson, I. C., & Canellos, G. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020104 · Cited by 467
SANTNER, S. J., FEIL, P. D., & SANTEN, R. J. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-1-29 · Cited by 406
Interactions of a series of coumarins with reactive oxygen species
Payá, M., Halliwell, B., & Hoult, J. R. S. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90002-z · Cited by 396
Selective Estrogen Receptor Modulators: Structure, Function, and Clinical Use
Osborne, C. K., Zhao, H. (., & Fuqua, S. A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3172 · Cited by 367
A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency
Schmidt, B., Selmer, T., Ingendoh, A., & Figurat, K. V. (1995) · Cell · doi:10.1016/0092-8674(95)90314-3 · Cited by 361
Geisler, J., King, N., Dowsett, M., Ottestad, L., Lundgren, S., Walton, P., Kormeset, P., & Lønning, P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.531 · Cited by 336
Lukatela, G., Krauss, N., Theis, K., Selmer, T., Gieselmann, V., von Figura, K., & Saenger, W. (1998) · Biochemistry · doi:10.1021/bi9714924 · Cited by 326
Selective estrogen receptor modulation
Jordan, V. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00059-5 · Cited by 315
Geisler, J., King, N. C., Anker, G. B., Ornati, G., di Salle, E., Lønning, P. E., & Dowsett, M. (1998) · PubMed · Cited by 314
Photophysical and (Photo)electrochemical Properties of a Coumarin Dye
Wang, Z.-S., Hara, K., Dan-oh, Y., Kasada, C., Shinpo, A., Suga, S., Arakawa, H., & Sugihara, H. (2005) · The Journal of Physical Chemistry B · doi:10.1021/jp044851v · Cited by 311
The Molecular Pharmacology of SERMs
McDonnell, D. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00177-0 · Cited by 299
Structure of a human lysosomal sulfatase
Bond, C. S., Clements, P. R., Ashby, S. J., Collyer, C. A., Harrop, S. J., Hopwood, J. J., & Guss, J. M. (1997) · Structure · doi:10.1016/s0969-2126(97)00185-8 · Cited by 297
Wolf, O. T., & Kirschbaum, C. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00021-1 · Cited by 287
Arimidex�: A potent and selective fourth-generation aromatase inhibitor
Plourde, P. V., Dyroff, M., & Dukes, M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682745 · Cited by 258
Jonat, W., Howell, A., Blomqvist, C., Eiermann, W., Winblad, G., Tyrrell, C., Mauriac, L., Roche, H., Lundgren, S., Hellmund, R., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00014-3 · Cited by 254
Treatment of Lymphedema of the Arms and Legs with 5,6-Benzo-[alpha]-pyrone
Casley-Smith, J. R., Morgan, R. G., & Piller, N. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310143291604 · Cited by 252
Bhatnagar, A. S., Häusler, A., Schieweck, K., Lang, M., & Bowman, R. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90460-3 · Cited by 246
Comparative Analyses of Mechanistic Differences Among Antiestrogens1
Wijayaratne, A. L., Nagel, S. C., Paige, L. A., Christensen, D. J., Norris, J. D., Fowlkes, D. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7164 · Cited by 244
Stanway, S. J., Purohit, A., Woo, L. W. L., Sufi, S., Vigushin, D., Ward, R., Wilson, R. H., Stanczyk, F. Z., Dobbs, N., Kulinskaya, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1996 · Cited by 238
Importance of estrogen sulfates in breast cancer
Pasqualini, J. R., Gelly, C., Nguyen, B.-L., & Vella, C. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90077-0 · Cited by 227
Estrogen, DNA damage and mutations
Roy, D., & Liehr, J. G. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00012-3 · Cited by 212
Pharmaceutical Prospects of Phytoestrogens
USUI, T. (2006) · Endocrine Journal · doi:10.1507/endocrj.53.7 · Cited by 210
Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
Suzuki, T., Nakata, T., Miki, Y., Kaneko, C., Moriya, T., Ishida, T., Akinaga, S., Hirakawa, H., Kimura, M., & Sasano, H. (2003) · PubMed · Cited by 187
Inactivation of Steroid Sulfatase by an Active Site-Directed Inhibitor, Estrone-3-O-Sulfamate
Purohit, A., Williams, G. J., Howarth, N. M., Potter, B. V. L., & Reed, M. J. (1995) · Biochemistry · doi:10.1021/bi00036a025 · Cited by 170
Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity
Reddy, N. S., Mallireddigari, M. R., Cosenza, S., Gumireddy, K., Bell, S. C., Reddy, E. P., & Reddy, M. V. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.05.016 · Cited by 165
Shan, B., Medina, J. C., Santha, E., Frankmoelle, W. P., Chou, T.-C., Learned, R. M., Narbut, M. R., Stott, D., Wu, P., Jaen, J. C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5686 · Cited by 164
Structure‐Activity Relationships of Synthetic Coumarins as HIV‐1 Inhibitors
Kostova, I., Raleva, S., Genova, P., & Argirova, R. (2006) · Bioinorganic Chemistry and Applications · doi:10.1155/bca/2006/68274 · Cited by 161
Howell, S. J., Johnston, S. R. D., & Howell, A. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2003.08.002 · Cited by 159
Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates
Woo, L. W. L., Purohit, A., Malini, B., Reed, M. J., & Potter, B. V. L. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00023-5 · Cited by 153
Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.
Utsumi, T., Yoshimura, N., Takeuchi, S., Ando, J., MARUTA, M., Maeda, K., & Harada, N. (1999) · PubMed · Cited by 144
Treatment with coumarin to prevent or delay recurrence of malignant melanoma
THORNES, R. D., Daly, L., Lynch, G., Breslin, B. K., Browne, H. Y., Browne, H. Y., Corrigan, T. P., Daly, P., Edwards, G., Gaffney, E. F., et al. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01377122 · Cited by 140
Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives
Stanchev, S., Momekov, G., Jensen, F., & Manolov, I. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.05.005 · Cited by 135
Raloxifene: A Selective Estrogen Receptor Modulator (SERM) with Multiple Target System Effects
Muchmore, D. B. (2000) · The Oncologist · doi:10.1634/theoncologist.5-5-388 · Cited by 133
Steroidal and Nonsteroidal Sulfamates as Potent Inhibitors of Steroid Sulfatase
Woo, L. W. L., Howarth, N. M., Purohit, A., Hejaz, H. A., Reed, M. J., & Potter, B. V. L. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970527v · Cited by 132
Liehr, J. G. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.3.273 · Cited by 130
An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin
Marshall, M. E., Mohler, J. L., Edmonds, K., Williams, B. R., Butler, K. M., Ryles, M., Weiss, L., Urban, D. A., Bueschen, A. J., Markiewicz, M., et al. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01377124 · Cited by 125
Design, Synthesis, and 3D QSAR of Novel Potent and Selective Aromatase Inhibitors
Leonetti, F., Favia, A. D., Rao, A., Aliano, R., Paluszcak, A., Hartmann, R. W., & Carotti, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049535j · Cited by 122
Selective Estrogen Receptor Modulators (SERMs)
Grese, T. A., & Dodge, J. A. (1970) · Current Pharmaceutical Design · doi:10.2174/138161280401221007111005 · Cited by 119
Novel coumarin derivatives of heterocyclic compounds as lipid-Lowering agents
Madhavan, G. R., Balraju, V., Mallesham, B., Chakrabarti, R., & Lohray, V. B. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00490-6 · Cited by 116
TEKMAL, R. R., Ramachandra, N., Gubba, S., Durgam, V. R., Mantione, J. R., Toda, K., Shizuta, Y., & Dillehay, D. L. (1996) · PubMed · Cited by 113
The Rarity of Liver Toxicity in Patients Treated with Coumarin (1, 2-Benzopyrone)
Cox, D. M., O’Kennedy, R. J., & THORNES, R. D. (1989) · Human Toxicology · doi:10.1177/096032718900800612 · Cited by 113
Nußbaumer, P., & Billich, A. (2004) · Medicinal Research Reviews · doi:10.1002/med.20008 · Cited by 108
von Bülow, R., Schmidt, B., Dierks, T., FIGURA, K. V., & Usón, I. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4297 · Cited by 106
Inhibition of chemical carcinogen-induced neoplasia by coumarins and alpha-angelicalactone.
Wattenberg, L. W., Lam, L. K. T., & Fladmoe, A. V. (1979) · PubMed · Cited by 104
Miyoshi, Y., Ando, A., Hasegawa, S., Ishitobi, M., Taguchi, T., Tamaki, Y., & Noguchi, S. (2003) · PubMed · Cited by 99
Phase II evaluation of coumarin (1,2‐benzopyrone) in metastatic prostatic carcinoma
Mohler, J. L., Gomella, L. G., Crawford, E. D., Glodé, L. M., Zippe, C. D., Fair, W. R., & Marshall, M. E. (1992) · The Prostate · doi:10.1002/pros.2990200208 · Cited by 97
Purohit, A., Vernon, K. A., Hummelinck, A. E. W., Woo, L. W. L., Hejaz, H. A., Potter, B. V. L., & Reed, M. J. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00196-9 · Cited by 95
Demers, L. M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682744 · Cited by 95
Genotoxicity of steroidal estrogens
Russo, J., & Russo, I. H. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.05.007 · Cited by 92
Recksiek, M., Selmer, T., Dierks, T., Schmidt, B., & FIGURA, K. V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6096 · Cited by 91
Purohit, A., Woo, L. W. L., Potter, B. V. L., & Reed, M. J. (2000) · PubMed · Cited by 90
Suppression of 7,12-Dimethylbenz(α) Anthracene-Induced Breast Carcinoma by Coumarin in the Rat
Feuer, G. M., Kellen, J. A., & Kovács, K. (2009) · Oncology · doi:10.1159/000225098 · Cited by 88
The Naturally Occurring Coumarins
Murray, R. D. H. (2002) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-6172-2_1 · Cited by 87
Chemical Aspects of Coumarin Compounds for the Prevention of Hepatocellular Carcinomas
Okamoto, T., Kobayashi, T., & Yoshida, S. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011053352622 · Cited by 83
The sulfamide motif in the design of enzyme inhibitors
Winum, J., Scozzafava, A., Montero, J., & Supuran, C. T. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.1.27 · Cited by 83
Yamamoto, T., Kitawaki, J., Urabe, M., Honjo, H., Tamura, T., Noguchi, T., Okada, H., Sasaki, H., Tada, A., Terashima, Y., et al. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90251-q · Cited by 82
Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates
Malini, B., Purohit, A., Ganeshapillai, D., et al. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00178-3 · Cited by 78
Biochemical and Biological Characterization of a Novel Anti-aromatase Coumarin Derivative
Chen, S., Cho, M., Karlsberg, K., Zhou, D., & Yuan, Y.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406847200 · Cited by 77
Aromatase inhibitors and their antitumor effects in model systems.
Brodie, A., Lü, Q., Liu, Y., & Long, B. J. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060205 · Cited by 75
Evaluation of the mechanism of aromatase cytochrome P450
Kao, Y., Korzekwa, K. R., Laughton, C. A., & Chen, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2001.01886.x · Cited by 72
Steroid sulphatase inhibitors for breast cancer therapy
Purohit, A., Woo, L. W. L., Chander, S. K., Newman, S. T., Ireson, C. R., Ho, Y., Grasso, A., Leese, M. P., Potter, B. V. L., & Reed, M. J. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00353-4 · Cited by 67
Active Site Directed Inhibition of Estrone Sulfatase by Nonsteroidal Coumarin Sulfamates
Woo, L. W. L., Purohit, A., Reed, M. J., & Potter, B. V. L. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950931z · Cited by 67
Residues Critical for Formylglycine Formation and/or Catalytic Activity of Arylsulfatase A
Knaust, A., Schmidt, B., Dierks, T., von Bülow, R., & FIGURA, K. V. (1998) · Biochemistry · doi:10.1021/bi9810205 · Cited by 66
TEKMAL, R. R., Kirma, N. B., Gill, K., & Fowler, K. A. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060307 · Cited by 66
What do we know about the mechanisms of aromatase inhibitor resistance?
Chen, S., Masri, S., Wang, X., Phung, S., Yuan, Y.-C., & Wu, X. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.012 · Cited by 64
Marshall, M. E., Butler, K. M., & Fried, A. (1991) · PubMed · Cited by 61
Liu, C., Strobl, J. S., Bane, S., Schilling, J. K., McCracken, M. A., Chatterjee, S. K., Rahim-Bata, R., & Kingston, D. G. I. (2003) · Journal of Natural Products · doi:10.1021/np030296x · Cited by 58
Ahmed, S., Owen, C. P., James, K. E., Sampson, L., & Patel, C. K. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023371210 · Cited by 57
Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors
Li, P., Milano, S. K., Kluth, L., & Rhodes, M. E. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00093-3 · Cited by 54
Design, Synthesis, and Biological Evaluation of Ellipticine−Estradiol Conjugates
Devraj, R. V., Barrett, J. F., Fernandez, J., Katzenellenbogen, J. A., & Cushman, M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602930 · Cited by 54
Raobaikady, B., Purohit, A., Chander, S. K., Woo, L. W. L., Leese, M. P., Potter, B. V. L., & Reed, M. J. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00049-9 · Cited by 53
Purohit, A., Woo, L. W. L., Singh, A., Winterborn, C. J., Potter, B. V. L., & Reed, M. (1996) · PubMed · Cited by 50
Lloyd, M. D., Pederick, R. L., NATESH, R., Woo, L. W. L., Purohit, A., Reed, M. J., Acharya, K. R., & Potter, B. V. L. (2005) · Biochemical Journal · doi:10.1042/bj20041037 · Cited by 50
Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models.
Brady, H. A., Desai, S. J., Gayo, L. M., Khammungkhune, S., McKie, J. A., O'Leary, E. C., Pascasio, L., Sutherland, M. K., Anderson, D. W., Bhagwat, S. S., et al. (2002) · PubMed · Cited by 49
Non-steroidal and steroidal sulfamates: new drugs for cancer therapy
Purohit, A., Woo, L. W. L., Barrow, D., Hejaz, H. A., Nicholson, R. I., Potter, B. V. L., & Reed, M. J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00428-7 · Cited by 49
Meegan, M. J., Hughes, R. B., Lloyd, D. G., Williams, D. C., & Zisterer, D. M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001119l · Cited by 49
Yoshimura, N., Harada, N., Bukholm, I., Kåresen, R., Børresen‐Dale, A., & Kristensen, V. N. (2003) · Breast Cancer Research · doi:10.1186/bcr746 · Cited by 45
Jacquot, Y., Bermont, L., Giorgi, H., Refouvelet, B., Adessi, G., Daubrosse, E., & Xicluna, A. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)01207-1 · Cited by 43
Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer.
Brodie, A. M., Lü, Q., Liu, Y., Long, B. J., WANG, J.-P., & Yue, W. (1998) · PubMed · Cited by 41
Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II
Vicker, N., Ho, Y. T., Robinson, J., Woo, L. W. L., Purohit, A., Reed, M. J., & Potter, B. V. L. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00009-x · Cited by 38
Lead identification of a potent benzopyranone selective estrogen receptor modulator
McKie, J. A., Bhagwat, S. S., Brady, H. A., Doubleday, M., Gayo, L. M., Hickman, M., Jalluri, R. K., Khammungkhune, S., Kois, A., Mortensen, D. S., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.081 · Cited by 38
Gotteland, M., May, E., May-Levin, F., Contesso, G., Delarue, J.-C., & Mouriesse, H. (1994) · Cancer · doi:10.1002/1097-0142(19940801)74:3<864::aid-cncr2820740312>3.0.co;2-n · Cited by 34
Are all aromatase inhibitors the same? A review of the current evidence
Jänicke, F. (2004) · The Breast · doi:10.1016/j.breast.2004.09.003 · Cited by 32
Recanatini, M., & Cavalli, A. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)10053-0 · Cited by 29
New aromatase inhibitors: More selectivity, less toxicity, unfortunately, the same activity
Castiglione‐Gertsch, M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00013-5 · Cited by 25
Sutherland, M. K., Lipps, S., Patnaik, N., Gayo, L. M., Khammungkune, S., Xie, W., Brady, H. A., Barbosa, M. S., Anderson, D. W., & Stein, B. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00179-0 · Cited by 21
Definition of the molecular mechanism of action of tissue-selective oestrogen-receptor modulators
McDonnell, D. P. (1998) · Biochemical Society Transactions · doi:10.1042/bst0260054 · Cited by 19
New fluorogenic substrate for the first continuous steroid sulfatase assay
Bilban, M., Billich, A., Auer, M., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00144-x · Cited by 17
Mouridsen, H. T., & Robert, N. J. (2005) · PubMed Central · Cited by 13
Kirkiacharian, S., Chidiack, H., Philibert, D., Velde, P. V. D., & Bouchoux, F. (1999) · PubMed · Cited by 11
Cited by
Benign by design: catalyst-free in-water, on-water green chemical methodologies in organic synthesis
Gawande, M. B., Bonifácio, V. D. B., Luque, R., Branco, P. S., & Varma, R. S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60025d · Cited by 674
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
Küpeli Akkol, E., Genç, Y., Karpuz, B., Sobarzo-Sánchez, E., & Capasso, R. (2020) · Cancers · doi:10.3390/cancers12071959 · Cited by 493
Coumarin heterocyclic derivatives: chemical synthesis and biological activity
Medina, F. G., Marrero, J. G., Macías-Alonso, M., González, M. C., Córdova-Guerrero, I., Teissier García, A. G., & Osegueda-Robles, S. (2015) · Natural Product Reports · doi:10.1039/c4np00162a · Cited by 469
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
Riveiro, M., De Kimpe, N., Moglioni, A., Vazquez, R., Monczor, F., Shayo, C., & Davio, C. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790936284 · Cited by 448
Nepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.018 · Cited by 435
Metadata
- Authors
- Musa, M., Cooperwood, J., & Khan, M. O.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-11-01
- Volume
- 15
- Issue
- 26
- Pages
- 2664-2679
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2148738581
- Cited by
- 538
- References
- 103
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.